Overview of matrix metalloproteinase expression in cultured human cells

Matrix Biology

Volumn 16, Issue 8, 1998, Pages 483-496

  Giambernardi, Troy A ^a   Grant, George M ^a   Taylor, Gail P ^a   Hay, Robert J ^b   Maher, Veronica M ^c   Mccormick, J Justin ^c   Klebe, Robert J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b AMERICAN TYPE CULTURE COLLECTION   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Collagenases; Gelatinases; Matrix metalloproteinases; Oncogenes; Stromelysins

Indexed keywords

CARCINOGEN; COLLAGENASE; GELATINASE A; GELATINASE B; MATRILYSIN; MATRIX METALLOPROTEINASE; MESSENGER RNA; NEUTROPHIL COLLAGENASE; STROMELYSIN; STROMELYSIN 2;

ARTICLE; BONE TUMOR; BREAST TUMOR; CELL IMMORTALIZATION; CELL TRANSFORMATION; COLON TUMOR; CONTROLLED STUDY; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOUTH TUMOR; OLIGONUCLEOTIDE PROBE; ONCOGENE; ONCOGENE H RAS; PRIORITY JOURNAL; PROSTATE TUMOR; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL;

EID: 0031915048     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(98)90019-1     Document Type: Article

References (90)

1. Abe, T., Mori, T., Kohno, K., Seiki, M., Hayakawa, T., Welgus, H.G., Hori, S. and Kuwano, M. : Expression of 72 kDa type IV collagenase and invasion activity of human glioma cells. Clin. Exp. Metastasis 12: 296-304, 1994.
2. Azzam, H.S., Arand, G., Lippman, M.E. and Thompson, E.W.: Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production. J. Nat. Cancer Inst. 85: 1758-1764, 1993.
3. Basset, P., Wolf, C., Rouyer, N., Bellocq, J., Rio, M. and Chambon, P.: Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior. Cancer 74: 1045-1049, 1994.
4. Belaaouaj, A., Shipley, J.M., Kobayashi, D.K., Zimonjic, D.B., Popescu, N., Silverman, G.A. and Shapiro, S.D.: Human macrophage metalloelastase. Genomic organization, chromosomal location, gene linkage, and tissue-specific expression. J. Biol. Chem. 270: 14568-14575, 1995.
5. Bernhard, E.J., Gruber, S.B. and Muschel, R.J.: Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. USA 91: 4293-4297, 1994.
6. Birkedal-Hansen, H.: Proteolytic remodeling of extracellular matrix. Curr. Opin. Cell Biol. 7: 728-735, 1995.
7. Boyd, M.R. and Paull, K.D.: Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Develop. Res. 34: 91-109, 1995.
8. Buttice, G. and Kurkinen, M.: A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-Tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J. Biol. Chem. 268: 7196-7204, 1993.
9. Buttice, G. and Kurkinen, M.: Oncogenes control stromelysin and collagenase gene expression. Contrib. Nephrol. 107: 101-107, 1994.
10. Callaghan, M.M., Lovis, R.M., Rammohan, C., Lu, Y. and Pope, R.M.: Autocrine regulation of collagenase gene expression by TNF-alpha in U937 cells. J. Leukocyte Biol. 59: 125-132, 1996.
11. Cao, J., Sato, H., Takino, T. and Seiki, M.: The C-terminal region of membrane type matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J. Biol. Chem. 270: 801-805, 1996.
12. Chang, J.C., Wysocki, A., Tchou-Wong, K.M., Moskowitz, N., Zhang, Y. and Rom, W.N.: Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51: 306-311, 1996.
13. Chen, D. and Klebe, R.J.: Controls for validation of relative reverse transcription-polymerase chain reaction (RT-PCR) assays. PCR Meth. Applic. 3: 127-129, 1993.
14. Chen, D., Magnuson, V.L., Hill, S., Arnaud, C., Steffensen, B. and Klebe, R.J.: Regulation of integrin gene expression by substrate adherence. J. Biol. Chem. 267: 23502-23506, 1992.
15. Chen, D., Magnuson, V.L., Steffensen, B. and Klebe, R.J.: Use of stock solutions to simplify mRNA quantitation by reverse transcription-polymerase chain reaction (RT-PCR) assays. PCR Meth. Applic. 2: 351-353, 1993.
16. Chomczynski, P. and Sacchi, N.: Single-step method of RNA isolation by acid guanidinum thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159, 1987.
17. Diatchenko, L., Lau, Y.-F.C., Campbell, A.P., Chenchik, A., Moqadam, F., Huang, B., Lukyanov, S., Lukyanov, K., Gurskaya, N., Sverdlov, E.D. and Siebert, P.D.: Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc. Natl. Acad. Sci. USA 93: 1-6, 1996.
18. Fessier, L.I., Duncan, K.G., Fessler, J.H., Salo, T. and Tryggvason, K.: Characterization of the procollagen IV cleavage products produced by a specific tumor collagenase. J. Biol. Chem. 259: 9783-9789, 1984.
19. Freije, J.M.P., Diez-Itza, I., Balbin, M., Sanchez, L.M., Blasco, R., Tolivia, J. and Lopez-Otin, C.: Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J. Biol. Chem. 269: 16766-16733, 1996.
20. Frisch, S.M. and Morisaki, J.H.: Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell. Biol. 10: 6524-6532, 1990.
21. Fry, D.G., Milam, L.D., Dillberger, J.E., Maher, V.M. and McCormick, J.J.: Malignant transformation of an infinite life span human fibroblast cell strain by transfection with v-Kiras. Oncogene 5: 1415-1418, 1990.
22. Gaire, M., Magbanua, Z., McDonnell, S., McNeil, L., Lovett, D.H. and Matrisian, L.M.: Structure and expression of the human gene for the matrix metalloproteinase matrilysin. J. Biol. Chem. 269: 3032-3040, 1994.
23. Graham, C.H., Connelly, I., MacDougall, J.R., Kerbel, R.S., Stetler-Stevenson, W.G. and Lala, P.K.: Resistance of malignant trophoblast cells to both the anti-proliferative and anti-invasive effects of transforming growth factor-beta. Exp. Cell Res. 214: 93-99, 1994.
24. Grant, G.M., Cobb, J.K., Castillo, B. and Klebe, R.J.: Regulation of matrix metalloproteinases following cellular transformation. J. Cell. Physiol. 167: 177-183, 1996.
25. Gutman, A. and Wasylyk, B.: The collagenase gene promoter contains a TPA and concogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9: 2241-2246, 1990.
26. Hagmeyer, B.M., Konig, H., Herr, I., Offinga, R., Zantema, A., VanDerEb, A.J., Herrlich, P. and Angel, P.: Adenovirus E1A negatively and positively modulates transcription of AP-1 dependent genes by dimer-specific regulation of the DNA binding and transactivation activities of Jun. EMBO J. 12: 3559-3572, 1993.
27. Hansen, C.M., Frandsen, T.L., Brunner, N. and Binderup, L.: 1a,25-dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin. Exp. Metastasis 12: 195-202, 1996.
28. Hasty, K.A., Jeffrey, J.J., Hibbs, M.S. and Welgus, H.G.: The collagen substrate specificity of human neutrophil collagenase. J. Biol. Chem. 262; 10048-10052, 1996.
29. Haupt, L.M., Thompson, E.W., Griffiths, L.R. and Irving, M.G.: IS-RT-PCR assay detection of MT-MMP in a human breast cancer cell line. Biochemi. Mol. Biol. Int. 39: 553-561, 1996.
30. Higashino, F., Yoshida, K., Noumi, T., Seiki, M. and Fujinaga, K.: Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10: 1461-1463, 1995.
31. Hoosein, N.M., Logothetis, C.J. and Chung, L.W.K.: Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on the invasive capacity of human prostatic carcinoma cells. J. Urol. 149: 1209-1213, 1996.
32. Hopkin, K.: Tumor evolution: Survival of the fittest cells. J. NIH Res. 8: 37-41, 1996.
33. Houde, M., Tremblay, P., Masure, S., Opdenakker, G., Oth, D. and Mandeville, R.: Synergistic and selective stimulation of gelatinase B production in macrophages by lipopolysaccharide, trans-retinoic acid and CGP 41251, a protein kinase C regulator. Biochim. Biophys. Acta 1310: 193-200, 1996.
34. Hurlin, P.J., Maher, V.M. and McCormick, J.J.: Malignant transformation of human fibroblasts caused by expression of a transfected T24 HRAS oncogene. Proc. Natl. Acad. Sci. USA 86: 187-191, 1989.
35. Imai, S. and Takano, T.: Loss of collagenase gene expression in immortalized clones of SV40 T antigen-transformed human diploid fibroblasts. Biochem. Biophys. Res. Commun. 189: 148-153, 1992.
36. Lacraz, S., Isler, P., Vey, E., Welgus, H.G. and Dayer, J.M.: Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269: 22027-22033, 1994.
37. 2+ and protein kinase C. Biochem. J. 290: 135-138, 1993.
38. Leyton, J., Manyak, M.J., Mukherjee, A.B., Miele, L., Mantile, G. and Patierno, S.R.: Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium. Cancer Res. 54: 3696-3699, 1996.
39. Liang, P., Averboukh, L., Keyomarsi, K., Sager, R. and Pardee, A.B.: Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. Cancer Res. 52: 6966-6968, 1992.
40. Lin, C.-C., Maher, V.M. and McCormick, J.J.: Malignant transformation of human fibroblast strain MSU-1.1 by v-fes requires an additional genetic change. Int. J. Cancer 63: 140-147, 1995.
41. Lin, C.-C., Wang, D., Maher, V.M. and McCormick, J.J.: Malignant transformation of a human fibroblast cell strain by transfection of a v-fes oncogene but not by transfection of a gag-human c-fes construct. Cell Growth Differ. 5: 1381-1387, 1994.
42. Liu, X.H. and Rose, D.P.: Suppression of type IV collagenase in MDA-MB-435 human breast cancer cells by eicosapentaenoic acid in vitro and in vivo. Cancer Lett. 92: 21-26, 1995.
43. Lohi, J., Lehti, K., Westermarck, J., Kähäri, V.M. and Keski-Oja, J.: Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate. Eur. J. Biochem. 239: 239-247, 1996.
44. Lund, L.R., Romer, J., Thomasset, N., Solberg, H., Pyke, C., Bissell, M.J., Keid, D. and Werb, Z.: Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122: 181-193, 1996.
45. MacDonald, N.J. and Steeg, P.S.: Molecular basis of tumor metastasis. Cancer Surveys 16: 175-199, 1993.
46. Mackay, A.R., Ballin, M., Pelina, M.D., Farina, A.R., Nason, A.M., Hartzler, J.L. and Thorgeirsson, U.P.: Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12: 168-184, 1992.
47. Masure, S., Billiau, A., Van Damme, J. and Opdenakker, G.: Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim. Biophysi. Acta 1054: 317-325, 1990.
48. McCormick, J.J., Kohler, S.K. and Maher, V.M.: Transfection of a myc gene as a means of generating infinite life span human fibroblast strains. Meth. Cell Sci. 17: 141-148, 1995.
49. McCormick, J.J. and Maher, V.M.: Analysis of the multistep nature of human carcinogenesis utilizing human fibroblasts. Radiat. Oncol. Invest. 3: 387-391, 1996.
50. Milam, S.B., Magnuson, V.L., Steffensen, B., Chen, D. and Klebe, R.J.: IL-1beta and prostaglandins regulate integrin mRNA expression. J. Cell. Physiol. 149: 173-183, 1991.
51. Monsky, W.L., Lin, C.Y., Aoyama, A., Kelly, T., Akiyama, S.K., Mueller, S.C., Chen, WT. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54: 5702-5710, 1994.
52. Morgan, T.L., Yang, D., Fry, D.G., Hurlin, P.J., Kohler, S.K., Maher, V.M. and McCormick, J.J.: Characteristics of an infinite life span diploid human fibroblast cell strain and a neardiploid strain arising from a clone of cells expressing a transfected v-myc oncogene. Exp. Cell Res. 197: 125-136, 1991.
53. Murphy, J.P., Murphy, G. and Reynolds, J.J.: The origin of matrix metalloproteinases and their familial relationships. PEBS Lett. 289: 4-7, 1996.
54. Okada, A., Bellocq, J., Rouyer, N., Chenard, M., Rio, M., Chambon, P. and Basset, P.: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl. Acad. Sci. USA 92: 2730-2734, 1995.
55. Panagakos, F.S. and Kumar, S.: Modulation of proteases and their inhibitors in immortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro. Inflammation 18: 243-265, 1994.
56. Pulyaeva, H., Bueno, J., Polette, M., Birembaut, P., Sato, H., Seiki, M. and Thompson, E.W.: MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin. Exp. Metastasis 15: 111-120, 1997.
57. Quantin, B., Murphy, G. and Breathnach, R.: Pump-1 cDNA codes for a protein with characteristics similar to those of classical collagenase family members. Biochemistry 28: 5327-5334, 1996.
58. Ray, J.M. and Stetler-Stevenson, W.G.: The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur. Respir. J. 7: 2062-2072, 1994.
59. Ries, C., Lottspeich, F., Dittmann, K.H. and Petrides, P.E.: HL-60 leukemia cells produce an autocatalytically truncated form of matrix metalloproteinase-9 with impaired sensitivity to inhibition by tissue inhibitors of metalloproteinases. Leukemia 10: 1520-1526, 1996.
60. Rose, D.P., Connolly, J.M. and Liu, X.H.: Effects of linoleic acid on the growth and metastasis of two human breast cancer cell lines in nude mice and the invasive capacity of these cell lines in vitro. Cancer Res. 54: 6557-6562, 1994.
61. Saarialho-Kere, U.K., Crouch, E.C. and Parks, W.C.: Matrix metalloproteinase matrilysin is constitutively expressed in adult human exocrine epithelium. J. Invest. Dermatol. 105: 190-196, 1995.
62. Sager, R., Sheng, S., Anisowicz, A., Sotiropoulou, G., Zou, Z., Stenman, G., Swisshelm, K., Chen, Z., Hendrix, M.J.C., Pemberton, P., Rafidi, K. and Ryan, K.: RNA genetics of breast cancer: Maspin as paradigm. Cold Spring Harbor Symp. Quant. Biol. 59: 537-546, 1994.
63. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J. and Seiki, M.: Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83, 1992.
64. Sato, H., Kita, M. and Seiki, M.: v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. J. Biol. Chem. 268: 23460-23468, 1993.
65. Sato, H. and Seiki, M.: Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405, 1993.
66. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E. and Seiki, M.: A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370: 61-65, 1994.
67. Schiemann, S., Ruckels, M., Engelholm, E.H., Schwirzke, M., Brunner, N. and Weidle, U.H.: Differential gene expression in human mammary carcinoma cells: Identification of a new member of a receptro family. Anticancer Res. 17: 13-20, 1997.
68. Schonthal, A., Herrlich, P., Rahmsdorf, H.J. and Ponta, H.: Requirement for fos gene expression in the transcriptional activation of collagenase by other oncogenes and phorbol esters. Cell 54: 325-334, 1988.
69. Senoir, R.M., Griffin, G.L., Fliszar, C.J., Shapiro, S.D., Goldberg, G.I. and Welgus, H.G.: Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266: 7870-7875, 1996.
70. Shapiro, S.D., Kobayashi, D.K. and Ley, T.J.: Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. J. Biol. Chem. 268: 23824-23829, 1993.
71. Shay, J.W., van der Haegen, B.A., Ying, Y. and Wright, W.E.: The frequency of immortalization of human fibroblasts and mammary epithelial cells transfected with SV40 large T-antigen. Exp. Cell Res. 209: 45-52, 1993.
72. Shindoh, M., Higashino, F., Kaya, M., Yasuda, M., Funaoka, K., Hanzawa, M., Hida, K, Kohgo, T., Amemiya, A., Yoshida, K. and Fujinaga, K.: Correlated expression of matrix metalloproteinases and ets family transcription factor E1A-F in invasive oral squamous-cell-carcinoma-derived cell lines. Am. J. Pathol. 148: 693-700, 1996.
73. Singh, G. and Foster, C.S.: Gross factors in treatment of non-healing corneal ulcers and recurrent erosions. Cornea 8: 45-53, 1989.
74. Stearns, M.E. and Wang, M.: Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. Oncology Res. 6: 195-201, 1994.
75. Steffensen, B., Magnuson, V.L., Potempa, C.L., Chen, D. and Klebe, R.J.: Alpha5 integrin subunit expression changes during myogenesis. Biochim. Biophys. Acta 1137: 95-100, 1992.
76. Sundareshan, P., Koster, J.J., Nagle, R.B. and Bowden, G.T.: Coordinated expression of matnlysin during TPA-induced apoptosis of LNCaP cells: two parallel processes affected by TPA. Cancer Lett. 113: 17-24, 1997.
77. Thompson, E.W, Paik, S., Brunner, N., Sommers, C.L., Zugmaier, G., Clarke, R., Shima, T.B., Torn, J., Donahue, S., Lippman, M.E., Martin, G.R. and Dickson, R.B.: J. Cell. Physiol. 150: 534-544, 1992.
78. Tienari, J., Pertovaara, L., Saksela, O., Lehtonen, E. and Vartio, T.: Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells. Int. J. Cancer 56: 219-223, 1994.
79. Tsuchiya, Y., Endo, Y., Sato, H., Okada, Y., Mai, M., Sasaki, T. and Seiki, M.: Expression of type-IV collagenases in human tumor cell lines that can form liver colonies in chick embryos. Int. J. Cancer 56: 46-51, 1994.
80. VanWart, H.E. and Birkedal-Hansen, H.: The cysteine switch: A principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA 87: 5578-5582, 1990.
81. Wang, T.N., Qian, X.-H., Granick, M.S., Solomon, M.P., Rothman, V.L., Berger, D.H. and Tuszynski, G.P.: Thrombospondin-1 (TSP-1) promotes the invasive properties of hyman breast cancer. J. Surg. Res. 63: 39-43, 1996.
82. Welgus, H.G., Jeffrey, J.J. and Eisen, A.Z.: The collagen substrate specificity of human skin fibroblast collagenase. J. Biol. Chem. 256: 9511-9515, 1996.
83. Weston, C.A. and Weeks, B.S.: bFGF stimulates U937 cell adhesion to fibronectin and secretion of gelatinase B. Biochemi. Biophys. Res. Commun. 228: 318-323, 1996.
84. Wilhelm, S.M., Collier, I.E., Kronberger, A., Eisen, A.Z., Marmer, B.L., Grant, G.A., Bauer, E.A. and Goldberg, G.I.: Human skin fibroblast stromelysin: Structure, glycosylation, Substrate specificity, and differential expression in normal and tumorigenic cells. Proc. Natl. Acad. Sci. USA 84: 6725-6729, 1996.
85. Wilhelm, S.M., Collier, I.E., Marmer, B.L., Eisen, A.Z., Grant, G.A. and Goldberg, G.I.: SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages [published erratum appears in J. Biol. Chem. 265: 22570, 1990 ]. J. Biol. Chem. 264: 17213-17221, 1989.
86. Wilson, D.M., Yang, D., Dillberger, J.E., Dietrich, S.E., Maher, V.M. and McCormick, J.J.: Malignant transformation of human fibroblasts by a transfected N-ras oncogene. Cancer Res. 50: 5587-5593, 1990a.
87. Wilson, D.M., Yang, D., Dillberger, J.E., Dietrich, S.E., Maher, V.M. and McCormick, J.J.: Malignant transformation of human fibroblasts by a transfected N-ras oncogene. Cancer Res. 50: 5587-5593, 1990b.
88. Yang, D., Kohler, S.K., Maher, V.M. and McCormick, J.J.: v-sis oncogene-induced transformation of human fibroblasts into cells capable of forming benign tumors. Carcinogenesis 15: 2167-2175, 1994.
89. Yang, D., Louden, C., Reinhold, D.S., Kohler, S.K., Maher, V.M. and McCormick, J.J.: Malignant transformation of human fibroblast cell strain MSU-1.1 by (")-7b,8a-dihydroxy-9a,10a-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene. Proc. Natl. Acad. Sci. USA 89: 2237-2241, 1992.
90. Zucker, S., Lysik, R.M., Malik, M., Bauer, B.A., Caamano, J. and Klein-Szanto, A.J.: Secretion of gelatinases and tissue inhibitors of metalloproteinases by human lung cancer cell lines and revenant cell lines: not an invariant correlation with metastasis. Int. J. Cancer 52: 366-371, 1992.